GSE159963
Epigenetic inhibitors
The project aims to looks at differential gene targets in the human Sezary syndrome HuT78 cell line when treated with epigenetic inhibitors romidepsin, F5446, and chaetocin compared to the vehicle treated cells (DMSO) for 72hrs. Overall design: Cell line HuT78 treated with chaetocin, F5446, romidepsin, and DMSO for 72hrs